stefano | Clinical Neuroscience | Innovative Research Award

Posted on 12/05/202512/05/2025 by Neuroscientists

Dr. Stefano | Clinical Neuroscience | Innovative Research Award

Dr. Stefano, Ospedale Santa Chiara Trento, Italy.

Dr. Stefano Branzoli is a highly accomplished cardiac surgeon with decades of experience spanning Italy, Belgium, and the United States. After completing his medical studies at the University of Pavia, he advanced through elite international training, including a fellowship at the Mayo Clinic. His career has focused on surgical innovation in cardiac electrophysiology, with particular emphasis on thoracoscopic ablation for atrial fibrillation, stroke prevention, and ventricular arrhythmias. Through his roles at Santa Chiara Hospital and Universitair Ziekenhuis Brussel, he has contributed extensively to both clinical practice and academic research.

Profile

Orcid

🧬 Early Academic Pursuits

Dr. Stefano Branzoli began his journey into medicine at the prestigious University of Pavia, where he earned his degree in Medicine and Surgery between 1992 and 1998. Driven by a deep curiosity for cardiovascular science, he embarked on rigorous postgraduate training, marking the start of an extraordinary career in cardiac surgery. His academic excellence soon opened international doors, including a coveted fellowship at the Mayo Clinic in Rochester, Minnesota.

🏥 Professional Endeavors

From 1999 to 2004, Dr. Branzoli honed his clinical expertise as a resident in cardiac surgery at the University of Pavia. He became board-certified after completing the USMLE in 2000, equipping him with transatlantic qualifications. Since 2005, he has served in the Cardiac Surgery Unit at Santa Chiara Hospital in Trento, Italy, while also expanding his reach as a specialist at the Universitair Ziekenhuis Brussel in Belgium since 2019. These dual roles reflect his commitment to advancing surgical standards across borders.Contributions to Cardiac ElectrophysiologyThroughout his career, Dr. Branzoli has been instrumental in the development and refinement of procedures targeting arrhythmias. His clinical and research contributions in thoracoscopic ablation for atrial fibrillation, stroke prevention, and epicardial ablation for ventricular arrhythmias have positioned him as a leading voice in electrophysiological cardiac surgery. He has been particularly focused on minimally invasive techniques that reduce patient recovery time while enhancing procedural efficacy.

🔬 Research Focus and Innovation

Dr. Branzoli’s research portfolio reflects his dedication to solving complex cardiovascular challenges. He has led and contributed to significant projects centered on atrial fibrillation, stroke prevention strategies, and novel ablative techniques. His work bridges the gap between traditional surgical approaches and cutting-edge electrophysiological interventions, helping shape the future of cardiac care through both clinical practice and investigative science.

🏅 Accolades and Recognition

Though modest in demeanor, Dr. Branzoli’s accomplishments have earned him respect in academic and clinical circles alike. His training at the Mayo Clinic—a global epicenter for cardiac research—along with his dual appointments in Italy and Belgium, speak volumes of his international reputation. His involvement in advanced cardiac rhythm management has earned recognition from peers and institutions aiming to elevate surgical excellence.

🌍 Impact and Influence

Beyond the operating theater, Dr. Branzoli’s influence is reflected in the widespread adoption of thoracoscopic ablation techniques and his mentorship of upcoming cardiac surgeons in Europe. By integrating cross-border expertise, he has played a vital role in aligning surgical standards and promoting collaborative research between institutions in Italy, Belgium, and beyond.

🔮 Legacy and Future Contributions

As medicine evolves toward personalized, minimally invasive therapies, Dr. Branzoli stands at the forefront of surgical innovation. His work continues to inspire new pathways in arrhythmia management and stroke prevention. With a career spanning continents and a mind open to continual learning, his legacy is defined not only by lives saved but also by knowledge passed on to future generations of cardiovascular specialists.

Publication

Title: Patients with Gastrointestinal Bleeding and Atrial Fibrillation: Potential Ideal Target for Epicardial Appendage Occlusion
Authors: Stefano Branzoli, Massimiliano Marini, Domenico Catanzariti, Cecilia Pravadelli, Luigi Pannone, Giovanni D’Onghia, Mauro Fantinel, Fabrizio Guarracini, Gaia Franceschini, Mirco Zadro et al.
Year: 2025

Title: Heart Team for Left Appendage Occlusion without the Use of Antithrombotic Therapy: The Epicardial Perspective
Authors: Stefano Branzoli, Fabrizio Guarracini, Massimiliano Marini, Giovanni D’Onghia, Domenico Catanzariti, Elettra Merola, Luciano Annicchiarico, Giulia Casagranda, Chiara Stegagno, Mauro Fantinel et al.
Year: 2022

✅ Conclusion

Dr. Branzoli’s enduring commitment to advancing cardiac surgery has had a meaningful impact on patient care, research, and education. With a legacy rooted in innovation, cross-cultural collaboration, and a passion for arrhythmia management, he continues to influence the evolving field of cardiovascular medicine. His work serves as a bridge between traditional surgical methods and modern electrophysiological therapies—ensuring that the future of heart care is not only safer and more effective but also profoundly human-centered.

Janine Hicks | Emerging Areas in Neuroscience |

Posted on 06/05/2025 by Neuroscientists

Dr. Janine Hicks | Emerging Areas in Neuroscience | Best Researcher Award

Dr. Janine Hicks, University of KwaZulu-Natal, South Africa.

Janine Louise Hicks is a distinguished South African academic and human rights advocate with over 30 years of experience in law, gender justice, and community development. Her academic journey includes degrees from the University of Cape Town, UNISA, Sussex University, and the University of KwaZulu-Natal, culminating in a Ph.D. focused on participatory development and social change. Currently a Senior Lecturer in Law at UKZN, she has played pivotal roles in both academia and civil society, offering expert legal and policy insights on gender equality, legislative reform, and international development frameworks. Janine has represented South Africa in global gender forums and contributed extensively to the analysis of state compliance with international gender conventions. Her leadership on non-profit boards and her participation in key policy spaces highlight her enduring commitment to transforming legal and social systems for marginalized communities.

Profile

Google Scholar

🎓 Early Academic Pursuits

Janine Louise Hicks embarked on her academic journey with a strong foundation in the humanities, earning a Bachelor of Arts degree from the University of Cape Town between 1987 and 1989. Driven by a passion for justice and human rights, she pursued a Bachelor of Laws (LLB) from UNISA, completing it in 1994. Her interest in development, social justice, and participatory governance led her to the University of Natal, where she further enriched her legal education from 1995 to 1996. Committed to understanding grassroots development, Janine advanced her studies internationally, obtaining an MA in Participation, Development and Social Change from the Institute of Development Studies at Sussex University in the UK in 2005. Her academic journey culminated in a Ph.D. from the University of KwaZulu-Natal (2019–2021), reflecting her commitment to scholarly inquiry in gender and development.

👩‍🏫 Professional Endeavors

Janine Hicks’s professional path spans more than three decades in the fields of social justice, community development, and human rights. Currently serving as a Senior Lecturer in the School of Law at the University of KwaZulu-Natal, she has spent the last eight years mentoring future leaders in law and justice. Her work has been rooted in providing legal insights and academic leadership while bridging theory and practice. Janine’s career also encompasses substantial experience with non-profit and civil society organizations, where she has held leadership roles on several boards, ensuring that gender and participatory approaches remain central to institutional mandates and development strategies.

📚 Contributions and Research Focus

Janine’s research has focused intensively on the intersections of gender, law, and development, particularly in assessing and enhancing state mechanisms for gender equality. Her work delves into policy and legislative analysis, gender mainstreaming in public planning, and aligning national frameworks with international gender justice protocols. She has contributed significantly to the evaluation of state compliance with global and regional gender conventions, provided critical reports to Parliament, and engaged in global forums such as the United Nations Commission on the Status of Women. Through her research and advocacy, she has offered comprehensive recommendations to bridge gender gaps in policy and practice, shaping institutional transformation in South Africa and beyond.

🏅 Accolades and Recognition

While Janine does not list formal professional memberships, her influence is evident in the high-level positions she has held within civil society. She has served as Chairperson of the Board of Trustees at The Valley Trust, Chairperson of the Board of Directors at the Community Law and Rural Development Centre, and Chairperson of Agenda Feminist Media—testaments to the trust placed in her leadership and strategic vision. Her commitment to justice and equality has made her a respected voice in policy circles and advocacy spaces, especially in the fields of gender rights and participatory development.

🌍 Impact and Influence

Janine’s work has created a lasting impact on the formulation and reform of gender-sensitive legislation, as well as on the capacity of institutions to respond to the needs of marginalized communities. Her gender analysis has shaped development programs, contributed to institutional frameworks, and ensured that women’s voices are amplified in governance processes. Her advisory role at the Denis Hurley Centre reflects her continued influence on public interest law and social equity programming. She has also played a vital role in international dialogue, influencing negotiation and resolution processes at global platforms.

🔍 Legacy and Future Contributions

As an educator, Janine is cultivating a new generation of legal scholars and social justice advocates. Her legacy lies not only in the research she has produced and the reforms she has helped shape, but also in her role as a mentor and thought leader in feminist legal education. Looking ahead, Janine is poised to continue her impactful research and policy engagement, furthering academic discourse around gender justice and participatory governance in both South African and international contexts.

💡 Vision for Inclusive Development

At the heart of Janine Hicks’s work is a vision for an inclusive and equitable society, driven by participation, transparency, and gender justice. Her multidisciplinary expertise—spanning law, development, and social change—positions her as a champion for rights-based development. Whether through academic research, civil society leadership, or international advocacy, Janine continues to be a vital force in ensuring that the principles of justice and equality are upheld in law and lived in practice.

Publication

Title: Community development and engagement with local governance in South Africa
Authors: I Buccus, D Hemson, J Hicks, L Piper
Year: 2008

Title: Public participation and local governance
Authors: I Buccus, D Hemson, J Hicks, L Piper
Year: 2007

Title: Crafting new democratic spaces: participatory policy-making in KwaZulu-Natal, South Africa
Authors: J Hicks, I Buccus
Year: 2008

Title: Strengthening women’s participation in local governance: Lessons and strategies
Author: J Hicks
Year: 2011

Title: Assessing the effectiveness of community based involvement
Author: J Hicks
Year: 2006

Title: Democratisation with inclusion: revisiting the role of ward committees
Authors: I Buccus, J Hicks
Year: 2008

Title: South Africa: Expanding into
Authors: D Budlender, J Hicks, L Vetten
Year: 2002

Title: Bringing women into local governance: a review of enabling mechanisms in South Africa
Author: J Hicks
Year: 2011

Title: Civil society and participatory policy making in South Africa: Gaps and opportunities
Authors: I Buccus, J Hicks
Year: 2011

Title: ‘The wages are low but they are better than nothing’: The Dilemma of Decent Work and Job Creation in South Africa
Authors: M Williams, E Webster, K von Holdt, N Southern, R Southall, K Skinner, …
Year: 2011

✅ Conclusion

Janine Hicks’s career reflects a powerful blend of scholarship, advocacy, and leadership. Her deep-rooted expertise in gender and development, combined with her legal acumen, has positioned her as a vital contributor to South Africa’s democratic and feminist legal discourse. Through education, research, and civic engagement, she continues to shape more inclusive policies and empower future changemakers. Her legacy is one of courage, compassion, and commitment to social justice—an inspiring model for interdisciplinary and impactful work in human rights and development.

Che Ping Cheng | Translational Neuroscience | Best Researcher Award

Posted on 02/05/2025 by Neuroscientists

Prof. Che Ping Cheng | Translational Neuroscience | Best Researcher Award

Prof. Che Ping Cheng, Wake Forest University School of Medicine, United States.

Dr. Che Ping Cheng, M.D., Ph.D., FAHA, is a distinguished cardiovascular physiologist and internal medicine specialist whose career has been dedicated to advancing the understanding of heart function and failure. From earning his medical degree in China to completing a Ph.D. in Physiology at Wayne State University, and later conducting pivotal postdoctoral research at Wake Forest School of Medicine, Dr. Cheng has consistently pursued excellence in science and education. His research on ventricular mechanics, volume loading, and heart failure has significantly influenced both experimental cardiology and clinical practice. Recognized as a Fellow of the American Heart Association, he is also a dedicated mentor, shaping the next generation of cardiovascular researchers through his academic leadership.

Profile

Scopus

🎓 Early Academic Pursuits

Dr. Che Ping Cheng’s journey into medicine and science began in Nanjing, China, where he earned his M.D. degree from Nanjing Railway Medical University in 1977. His early academic path reflected a deep interest in understanding the intricacies of human health, particularly in cardiovascular physiology. Driven by a desire to expand his knowledge and research capabilities, Dr. Cheng pursued his Ph.D. in Physiology at Wayne State University School of Medicine in Detroit, Michigan, completing his degree in 1986. Under the mentorship of Dr. Robert S. Shepard, his doctoral work focused on exploring the mechanisms of cardiovascular response to volume loading in a canine model with tricuspid valvulectomy, setting a strong foundation for his lifelong focus on heart function and disease mechanisms.

🩺 Professional Endeavors

Following his academic training, Dr. Cheng embarked on postdoctoral studies at the Bowman Gray School of Medicine (now part of Wake Forest School of Medicine), where he continued to cultivate his expertise in internal medicine and cardiovascular physiology. Between 1986 and 1988, he served as a Postdoctoral Fellow under the guidance of Dr. William C. Little. His research during this period focused on ventricular dynamics and the physiological factors affecting active ventricular filling, which would later inform his broader work on heart failure and cardiac function. Dr. Cheng has since remained at Wake Forest School of Medicine, where he is currently a distinguished member of the Section on Cardiovascular Medicine.

🧪 Contributions and Research Focus

Dr. Cheng’s career has been characterized by a deep commitment to advancing the understanding of cardiac hemodynamics, ventricular interaction, and heart failure mechanisms. His research has explored how ventricular function responds under altered physiological states, and how these responses inform disease progression and treatment strategies. His early animal model studies have provided critical insights into the interplay between structural and functional changes in the heart, especially in the context of diastolic dysfunction and volume overload conditions. Dr. Cheng has also made significant strides in translating these findings to clinical contexts, influencing how cardiologists approach diagnosis and therapy.

🏅 Accolades and Recognition

Throughout his career, Dr. Cheng has received considerable recognition for his scholarly contributions. He is a Fellow of the American Heart Association (FAHA), an honor that reflects his standing in the field of cardiovascular research and his commitment to scientific excellence. His work has earned the respect of colleagues and institutions alike, leading to numerous invitations to contribute to collaborative projects, serve on peer-review panels, and mentor future generations of cardiovascular researchers.

🌍 Impact and Influence

Dr. Cheng’s work has had a lasting impact on both experimental and clinical cardiology. By elucidating the mechanistic basis of ventricular dysfunction, he has helped shift paradigms in heart failure management, particularly in the areas of ventricular interdependence and preload responsiveness. His research findings are frequently cited in textbooks and high-impact journals, and they continue to inform guidelines for cardiac care and interventions. Through his work at Wake Forest and beyond, Dr. Cheng has played a pivotal role in bridging laboratory discoveries with bedside applications.

👨‍🏫 Legacy and Mentorship

As a respected mentor and educator, Dr. Cheng has dedicated a significant portion of his career to training medical students, residents, and postdoctoral fellows. His mentorship has influenced numerous emerging scholars in cardiovascular medicine, many of whom have gone on to successful academic and clinical careers. His guidance combines a rigorous scientific approach with a deep sense of responsibility to patient care and scientific integrity, shaping a legacy that extends well beyond his own research output.

🔬 Future Contributions and Vision

Looking ahead, Dr. Cheng remains committed to the advancement of cardiovascular research, with a continued focus on uncovering the cellular and mechanical determinants of heart disease. His vision includes fostering collaborative projects that integrate biomedical engineering, imaging, and computational modeling to further understand cardiac performance. With decades of experience and a forward-thinking approach, Dr. Cheng’s future contributions are poised to leave a lasting mark on the field of translational cardiovascular medicine.

Publication

Title: Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension
Authors: Sun, Xiaoqiang; Cao, Jing; Chen, Zhe; Ferrario, Carlos M.; Cheng, Cheping
Year: 2023
Journal: Heliyon

Title: Calmodulin-dependent protein kinase II activation promotes kidney mesangial expansion in streptozotocin-induced diabetic mice
Authors: Mikhailov, Alexei V.; Liu, Yixi; Cheng, Hengjie; Lin, Jen Jar; Cheng, Cheping
Year: 2022
Journal: Heliyon

Title: Chronic GPR30 agonist therapy causes restoration of normal cardiac functional performance in a male mouse model of progressive heart failure: Insights into cellular mechanisms
Authors: Zhang, Xiaowei; Li, Tiankai; Cheng, Hengjie; Groban, Leanne; Cheng, Cheping
Year: 2021
Journal: Life Sciences

Title: Chronic Ca2+/calmodulin-dependent protein Kinase II inhibition rescues advanced heart failure
Authors: Liu, Yixi; Shao, Qun; Cheng, Hengjie; Zhao, David Xiao Ming; Cheng, Cheping
Year: 2021
Journal: Journal of Pharmacology and Experimental Therapeutics

Title: The Angiotensin-(1–12)/Chymase axis as an alternate component of the tissue renin angiotensin system
Authors: Ferrario, Carlos M.; Groban, Leanne; Wang, Hao; Sun, Xuming; Ahmad, Sarfaraz
Year: 2021
Journal: Molecular and Cellular Endocrinology

Title: Reversal of angiotensin-(1–12)-caused positive modulation on left ventricular contractile performance in heart failure: Assessment by pressure-volume analysis
Authors: Li, Tiankai; Zhang, Zhi; Zhang, Xiaowei; Ferrario, Carlos M.; Cheng, Cheping
Year: 2020
Journal: International Journal of Cardiology

Title: Female Heart Health: Is GPER the Missing Link?
Authors: Groban, Leanne; Tran, Q. K.; Ferrario, Carlos M.; Wang, Hao; Lindsey, Sarah H.
Year: (Not specified, but likely 2020 or 2021)
Journal: (Not specified)

🏁 Conclusion

Dr. Cheng’s legacy is one of intellectual rigor, clinical relevance, and mentorship. His work has not only deepened the scientific understanding of cardiac physiology but has also shaped modern approaches to diagnosing and managing heart failure. With a career spanning continents and disciplines, Dr. Cheng continues to be a guiding force in cardiovascular medicine, and his future contributions are anticipated to further advance the frontiers of heart research and patient care.

CARMINA MONTOLIU | Clinical Neuroscience | Best Researcher Award

Posted on 26/04/2025 by Neuroscientists

Prof. Dr. CARMINA MONTOLIU | Clinical Neuroscience | Best Researcher Award

Prof. Dr. CARMINA MONTOLIU, UNIVERSIDAD DE VALENCIA/INCLIVA, Spain.

Carmina Montoliu Felix, a Valencia-born scientist and educator, is a distinguished Catedrática de Universidad at the Universidad de Valencia, specializing in Cellular Biology and Pathology. With a strong foundation in biomedical sciences and a dual role in both academia and clinical research through INCLIVA, she has become a key figure in translational medicine in Spain. Her work focuses on uncovering cellular mechanisms of disease, supported by national recognition such as her Group A classification by ISCIII. With extensive contributions indexed on platforms like ORCID and Scopus, she has gained international visibility and continues to influence the fields of pathology and biomedicine.

Profile

Orcid

🎓 Early Academic Pursuits

Carmina Montoliu Felix was born in Valencia, where she also pursued her academic career rooted in the life sciences. Her early interest in biology and medical sciences led her through a rigorous academic pathway that would eventually shape her into a leading figure in cellular pathology. With a profound dedication to understanding human disease at the cellular level, she cultivated a strong foundation in biology, which became the cornerstone of her future specialization in Cellular Biology and Pathology. These formative years instilled in her a passion for translational research, which continues to drive her work.

🏛️ Professional Endeavors

Currently serving as a Catedrática de Universidad at the Facultad de Medicina y Odontología of the Universidad de Valencia, Carmina Montoliu Felix holds a prestigious position within the Departamento de Patología, specifically in the Unidad de Biología. She achieved this distinguished academic rank on November 3, 2023, under BOE nº 274, a recognition of her academic excellence and contributions to higher education. Alongside her academic post, she is also an investigadora adscrita at the Fundación INCLIVA, playing a dual role in both teaching and active biomedical research. Her employment reflects the seamless integration between university instruction and clinical research aimed at improving patient outcomes.

🧬 Contributions and Research Focus

Carmina Montoliu Felix has been a pivotal contributor to the field of Cellular Biology, with specific expertise in Pathology (Área 661). Since February 29, 2012, she has been classified as a Group A Researcher within the Instituto de Salud Carlos III (ISCIII) framework. Her research activities are aligned with the Programa de Estabilización de Investigadores and the Sistema Nacional de Salud (I3SNS), focusing on intensifying biomedical research and fostering translational discoveries. Her scientific work is characterized by its interdisciplinary nature and commitment to uncovering the molecular basis of diseases, contributing significantly to both national and international health research landscapes.

🏅 Accolades and Recognition

Dr. Montoliu Felix’s academic excellence has been affirmed through numerous accolades, including the Group A classification by the Comisión Técnica de Evaluación de Recursos Humanos del ISCIII, one of the highest distinctions for biomedical researchers in Spain. Her appointment as a full professor is a testament to her leadership in medical education and scientific research. She is widely recognized among her peers for her scholarly impact, rigor, and commitment to nurturing future scientists and medical professionals.

🌍 Impact and Influence

Her work not only resonates within academic circles but also extends into clinical research through her active role at INCLIVA. By integrating research and practice, Carmina Montoliu Felix exemplifies how scientific inquiry can lead to tangible health benefits. Her influence spans collaborations with national healthcare systems and academic institutions, reinforcing her role as a key figure in the biomedical field. Through platforms such as ORCID and Scopus (ORCID ID: 0000-0002-4740-4788; Scopus ID: 6701923138), her contributions are accessible globally, further amplifying her scientific impact.

🔬 Legacy and Future Contributions

With a career marked by consistent advancement and dedication to discovery, Carmina Montoliu Felix is poised to continue shaping the future of cellular pathology and biomedical research in Spain and beyond. Her dual engagement in academia and clinical research ensures that her legacy will include both scientific breakthroughs and a generation of inspired students and researchers. Looking ahead, she is expected to further expand the integration of molecular biology into clinical diagnostics, ultimately improving patient care through science.

📚 A Life Committed to Science and Society

Beyond her technical expertise and professional roles, Carmina Montoliu Felix embodies the ideals of a scholar deeply committed to the betterment of society through science. Her residence and professional base in Valencia, her continuous academic contributions, and her service within public institutions paint the portrait of a researcher who bridges the lab and the community. Through her enduring efforts, she not only advances knowledge but also enhances the collective understanding of human health and disease.

Publication

Title: Valproate Damaging Effect on Erythrocyte Metabolism as a Decisive Factor in the Development of Encephalopathy
Authors: Lyudmila Tikhonova; Eugene Maevsky; Carmina Montoliu; Elena Kosenko
Year: 2025

Title: Ammoniagenic Action of Valproate without Signs of Hepatic Dysfunction in Rats: Possible Causes and Supporting Evidence
Authors: Gubidat Alilova; Lyudmila Tikhonova; Carmina Montoliu; Elena Kosenko
Year: 2024

Title: Automatic Video-Oculography System for Detection of Minimal Hepatic Encephalopathy Using Machine Learning Tools
Authors: Alberto Calvo Córdoba; Cecilia Elisabet García Cena; Carmina Montoliu
Year: 2023

Title: Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients
Authors: Alessandra Fiorillo; Juan José Gallego Roig; Franc Casanova; Amparo Urios; MP Ballester; Teresa San-Miguel; Javier Megías Vericat; Elena Kosenko; Tosca J; Maria-Pilar Rios et al.
Year: 2023

Title: Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver Disease
Authors: Alessandra Fiorillo; Juan José Gallego Roig; Franc Casanova; Carla Giménez-Garzó; Amparo Urios; MP Ballester; Lucia Durbán; Maria-Pilar Rios; Javier Megías Vericat; Teresa San-Miguel et al.
Year: 2023

Title: Erythrocytes Functionality in SARS-CoV-2 Infection: Potential Link with Alzheimer’s Disease
Authors: Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Carmina Montoliu
Year: 2023

Title: Plasma Extracellular Vesicles Play a Role in Immune System Modulation in Minimal Hepatic Encephalopathy
Authors: Juan José Gallego; Alessandra Fiorillo; Franc Casanova-Ferrer; Amparo Urios; MP Ballester; Lucia Durbán; Javier Megías; Teresa Rubio; Andrea Cabrera-Pastor; Desamparados Escudero-García et al.
Year: 2022

Title: Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression
Authors: Teresa San-Miguel; Javier Megías; Daniel Monleon; Lara Navarro Cerveró; Lisandra Muñoz; Carmina Montoliu; Marina Meri; Pedro Roldán; Miguel Cerdá-Nicolás; Concha López-Ginés
Year: 2022

Title: Is NMDA-Receptor-Mediated Oxidative Stress in Mitochondria of Peripheral Tissues the Essential Factor in the Pathogenesis of Hepatic Encephalopathy?
Authors: Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Carmina Montoliu
Year: 2022

Title: A New Score Unveils a High Prevalence of Mild Cognitive Impairment in Patients with Nonalcoholic Fatty Liver Disease
Authors: Carla Giménez-Garzó; Alessandra Fiorillo; MP Ballester; Juan José Gallego Roig; Franc Casanova-Ferrer; Amparo Urios; Salvador Benlloch; Marti-Aguado D; Teresa San-Miguel; Tosca J et al.
Year: 2021

✅ Conclusion

Carmina Montoliu Felix’s career reflects a rare blend of scientific rigor, academic leadership, and social impact. Her journey from student to full professor showcases her dedication to advancing both knowledge and healthcare. As she continues to lead research at the intersection of cellular biology and clinical application, her legacy will not only be measured in published studies and prestigious titles, but also in the real-world health outcomes and inspired minds her work cultivates. Her future contributions promise to deepen our understanding of disease and strengthen the bridge between science and society.

Clotilde Guidetti | Neuropharmacology | Best Researcher Award

Posted on 22/04/2025 by Neuroscientists

Dr. Clotilde Guidetti | Neuropharmacology | Best Researcher Award

Dr. Clotilde Guidetti, Harvard Medical School, Massachusetts General Hospital, United States.

Clotilde Guidetti is an accomplished early-career physician-scientist specializing in Child and Adolescent Neuropsychiatry. With a classical foundation and medical training from the University of Genoa, she excelled academically, earning multiple merit awards and graduating Summa Cum Laude. She completed her specialized residency at the Catholic University of Rome, further refining her clinical expertise. Clotilde’s research focus lies in neurodevelopmental disorders, behavioral interventions, and psychopharmacology in pediatric populations. She has already demonstrated promise as an independent researcher through competitive grant submissions and award-winning conference presentations. Based in Boston, she is actively shaping a career that bridges clinical care and scientific innovation.

Profile

Scopus

🎓 Early Academic Pursuits

Clotilde Guidetti began her academic journey with a deep-rooted passion for understanding the human mind and behavior. She earned her High School Diploma in Classical Studies from the prestigious State High School Andrea D’Oria, an early indication of her strong intellectual curiosity and dedication to learning. This foundation in classical education provided her with a broad humanistic perspective that continues to inform her clinical and research approach. She then pursued her Medical Degree at the University of Genoa, where she graduated Summa Cum Laude in 2020. Her academic record was consistently marked by distinction, earning multiple Academic Merit Awards for clinical excellence during her medical studies.

🧠 Professional Endeavors

Following her graduation, Dr. Guidetti further specialized in the field of Child and Adolescent Neuropsychiatry through a rigorous residency program at the Catholic University of Rome. Completed in November 2024, her residency was also distinguished with Summa Cum Laude honors, reflecting both her clinical acumen and compassionate engagement with young patients. Her professional training combined intensive clinical work with scholarly research, preparing her to address complex neurodevelopmental and psychiatric disorders in children and adolescents.

🔬 Contributions and Research Focus

Dr. Guidetti’s primary research interests lie at the intersection of neurodevelopment, behavioral disorders, and psychopharmacology in pediatric populations. Her clinical insights are deeply enriched by her scientific inquiries, particularly those focused on the early diagnosis and personalized treatment of neuropsychiatric conditions. She has already begun shaping her independent research path, as seen in her recent submission for the Brain & Behavior Research Foundation Young Investigator Grant in January 2025. Her project, currently under review, reflects her growing reputation as an emerging scholar in the domain of pediatric neuropsychiatry.

🏅 Accolades and Recognition

Throughout her academic and clinical journey, Clotilde Guidetti has been the recipient of multiple honors that highlight her outstanding abilities. These include three Academic Merit Awards from the University of Genoa and a prestigious Erasmus Socrates Fellowship in 2017–2018, which broadened her training in an international context. In 2022, she received the Attilio Sabato Award from the Società Italiana di Neuropsicofarmacologia (SINPF) for the best poster presentation—an achievement that not only celebrated her communication skills but also her innovative scientific thinking in neuropsychopharmacology.

🌍 Impact and Influence

Though early in her career, Dr. Guidetti has already begun to leave a meaningful mark on the field of child and adolescent mental health. Her dual focus on clinical excellence and academic inquiry ensures that her work resonates both within medical communities and in the lives of the families she serves. With a practice grounded in empathy and scientific rigor, she exemplifies the new generation of clinician-scientists committed to transforming mental health care for the most vulnerable populations.

🧬 Legacy and Future Contributions

As she looks to the future, Clotilde Guidetti aims to expand her contributions to academic psychiatry through collaborative research, cross-disciplinary studies, and the mentorship of emerging professionals in the field. Her continued involvement in national and international research networks promises to amplify her influence, paving the way for innovative treatments and holistic models of care in pediatric neuropsychiatry. Her vision is firmly centered on early intervention, neurodevelopmental resilience, and the integration of clinical practice with cutting-edge neuroscience.

📚 Academic Footprint

Dr. Guidetti currently resides and practices in Boston, Massachusetts, where she continues to build her clinical and research profile. Her dual base—rooted in Italy and expanding into the United States—places her at the nexus of transatlantic collaboration. With each project and presentation, she further refines her expertise and extends her academic footprint, fostering a dynamic career defined by global engagement, intellectual integrity, and unwavering commitment to child and adolescent mental health.

Publication

Title: Antidepressants in the acute treatment of post-traumatic stress disorder in adults: a systematic review and meta-analysis
Authors: Guidetti, Clotilde; Feeney, Anna; Hock, Rebecca S.; Fava, Maurizio; Papakostas, George I.
Year: 2024

📝 Conclusion

Dr. Guidetti embodies the ideal of a compassionate clinician and rigorous academic, poised to make significant contributions to the future of child and adolescent mental health. Her career so far reflects a seamless blend of scholarly excellence, clinical sensitivity, and a drive to push the boundaries of understanding in neuropsychiatry. As she continues to expand her research and collaborative efforts globally, her work promises to influence both scientific discourse and practical approaches in mental health care—building a legacy rooted in evidence, empathy, and innovation.

Edyta GLOGOWSKA | Cell Metabolism | Best Researcher Award

Posted on 22/04/2025 by Neuroscientists

Dr. Edyta Glogowska | Cell Metabolism | Best Researcher Award

Dr. Edyta Glogowska, CNRS-IPMC-UniCA, France.

Dr. Edyta Glogowska is a passionate and accomplished biomedical researcher with a strong academic background in biotechnology and life sciences. From her early beginnings in dental engineering to earning a PhD in red blood cell physiology from the University Pierre and Marie Curie, her academic journey reflects a deep commitment to advancing human health through science. Her postdoctoral research at the Institute of Molecular and Cellular Pharmacology (IPMC) highlights her expertise in cell physiology, electrophysiology, and molecular biology, with a special focus on macrophage Piezo1 channels and their role in atherosclerosis. She is a skilled communicator and team collaborator, recognized for her academic excellence and contributions to hematology and immunopathology.

Profile

Scopus

🎓 Early Academic Pursuits

Dr. Edyta Glogowska’s journey into the world of life sciences began with a strong foundation in biotechnology and medical sciences. She earned her Master of Engineering in Biotechnology Processing from Wroclaw University of Science and Technology, where she graduated with highest honors. Even earlier, she had already laid a unique cornerstone for her biomedical interests through specialized training as a Dental Engineer at the Marie Curie Medical Vocational School. Her pursuit of deeper scientific knowledge led her to France, where she undertook her PhD in Biological and Life Sciences at the University Pierre and Marie Curie, Paris VI. Conducted at the prestigious Station Biologique in Roscoff, her doctoral research focused on red blood cell physiology and was awarded with the highest honors—a testament to her early dedication and scientific promise.

🔬 Professional Endeavors

Dr. Glogowska’s professional career has been marked by a steadfast commitment to cell and molecular biology, electrophysiology, and the biochemistry of proteins. Her postdoctoral research at the Institute of Molecular and Cellular Pharmacology (IPMC) in Sophia Antipolis (2021–2024) showcases her hands-on expertise with mice experimentation and patch-clamp techniques, placing her at the cutting edge of biomedical research. Working under the guidance of Dr. Eric Honoré, she explored the role of macrophage Piezo1 channels regulated by lipids, a study with far-reaching implications in understanding and potentially treating atherosclerosis.

🧬 Contributions and Research Focus

Throughout her academic and postdoctoral years, Dr. Glogowska has focused her research on the physiology and pathophysiology of cells, particularly red blood cells and immune cells like macrophages. Her interest lies in understanding how cellular mechanisms contribute to broader medical conditions, such as cardiovascular diseases. By integrating electrophysiology with molecular biology, she brings a comprehensive approach to biomedical questions, bridging the gap between basic research and therapeutic application. Her work on Piezo1 not only contributes to our understanding of mechanotransduction in macrophages but also holds promise for future translational research.

🏅 Accolades and Recognition

Dr. Glogowska’s scholarly excellence has been consistently recognized. She graduated with highest honors both for her Master’s and PhD degrees, a rare academic distinction that underscores her dedication and intellectual rigor. She has also been an active member of the French Society of Hematology, aligning herself with leading experts in her field and staying abreast of the latest developments in blood cell research. These accolades reflect her respected standing within the scientific community.

🌍 Impact and Influence

Beyond technical expertise, Dr. Glogowska is praised for her team coordination and communication skills, qualities that have enabled her to contribute meaningfully to collaborative research environments. Her scientific efforts in understanding lipid–ion channel interactions in macrophages directly influence the broader field of cardiovascular immunology. By elucidating the role of Piezo1 channels in inflammatory processes, her research provides foundational knowledge that can inspire novel pharmacological interventions.

🔎 Legacy and Future Contributions

Dr. Glogowska continues to strive toward a future where her research leads to medical breakthroughs in inflammation and cardiovascular disease. She is particularly interested in translational science, where laboratory discoveries transition into clinical applications. Her strong background in biotechnology, dentistry, and molecular biology uniquely equips her to explore cross-disciplinary challenges in human health. As she advances, she aims to bridge research with clinical solutions, contributing to a legacy of innovation in life sciences.

Publication

Title: Potentiation of macrophage Piezo1 by atherogenic 7-ketocholesterol
Authors: Edyta Glogowska, Gregor P. Jose, Ana Rita Dias Araújo, Laurent Yvan-Charvet, Éric R. Honoré
Year: 2025

Title: Piezo1 in PASMCs: Critical for Hypoxia-Induced Pulmonary Hypertension Development
Authors: Fenja Knoepp, Shariq Abid, Amal Houssaïni, Éric R. Honoré, Serge Adnot
Year: 2025

Title: Pharmacological activation of PIEZO1 in human red blood cells prevents Plasmodium falciparum invasion
Authors: Rakhee Lohia, Benoit Allegrini, Laurence Berry, Éric R. Honoré, Kai Wengelnik
Year: 2023

Title: A machine-learning algorithm integrating baseline serum proteomic signatures predicts exercise responsiveness in overweight males with prediabetes
Authors: Candela Diaz-Canestro, Jiarui Chen, Yan Liu, Michael Andrew Tse, Aimin Xu
Year: 2023

Title: Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects
Authors: Kang Chen, Lai Yee Cheong, Yuan Gao, Hannah Xiaoyan Hui, Aimin Xu
Year: 2022

Title: Author Correction: Adipocyte Piezo1 mediates obesogenic adipogenesis through the FGF1/FGFR1 signaling pathway in mice
Authors: Shengpeng Wang, Shuang Cao, Malika Arhatte, Éric R. Honoré, Stefan Offermanns
Year: (Correction Published) — Likely 2021 or 2022

Title: Piezo1 and Piezo2 foster mechanical gating of K2P channels
Authors: Edyta Glogowska, Malika Arhatte, Franck C. Chatelain, Amanda Jane Patel, Éric R. Honoré
Year: 2021

Title: Adipocyte Piezo1 mediates obesogenic adipogenesis through the FGF1/FGFR1 signaling pathway in mice
Authors: Shengpeng Wang, Shuang Cao, Malika Arhatte, Éric R. Honoré, Stefan Offermanns
Year: 2020

Title: Piezo Ion Channels in Cardiovascular Mechanobiology
Authors: Dominique Douguet, Amanda Jane Patel, Aimin Xu, Paul Michel Vanhoutte, Éric R. Honoré
Year: (Not explicitly stated, likely ~2020 based on context)

Title: TMEM33 regulates intracellular calcium homeostasis in renal tubular epithelial cells
Authors: Malika Arhatte, Gihan S. Gunaratne, Charbel El Boustany, Éric R. Honoré, Amanda Jane Patel
Year: 2019

✅ Conclusion

Driven by curiosity and guided by precision, Dr. Glogowska continues to make meaningful strides in biomedical research. Her work stands at the intersection of basic science and medical application, with the potential to influence future therapeutic strategies for cardiovascular and inflammatory diseases. With her versatile skill set and visionary approach, she is well-positioned to leave a lasting impact on the scientific and medical communities. As she moves forward, Dr. Glogowska aspires to further bridge laboratory discoveries with clinical innovations, fostering a legacy of scientific excellence and translational breakthroughs.

Handrean Soran | Clinical Neuroscience | Best Researcher Award

Posted on 21/04/2025 by Neuroscientists

Prof. Handrean Soran | Clinical Neuroscience | Best Researcher Award

Prof. Handrean Soran, Manchester University NHS Foundation Trust, United Kingdom.

Dr. Handrean Soran is a distinguished British endocrinologist and researcher with expertise in diabetes, endocrinology, and cardiovascular diseases. His academic journey began in Iraq and advanced through the UK, where he earned prestigious medical qualifications, including an MD in Medicine and MSc in Diabetes and Endocrinology. Throughout his career, Dr. Soran has contributed significantly to research on the relationship between diabetes and cardiovascular health, publishing extensively in high-impact journals like The New England Journal of Medicine and Lancet. His work has garnered global recognition, including an H-index of 49 and numerous accolades, solidifying his position as a leader in his field.

Profile

Google Scholar

Early Academic Pursuits 📚

Handrean Soran’s academic journey began in the Kurdistan region of Iraq, where he completed his A-levels with an impressive score of 94.5% from Sulemani High School in 1985. His drive for knowledge led him to pursue his MBChB at Al-Mustansyria University in Baghdad, Iraq, graduating in 1990. This foundational education set the stage for a career dedicated to medical research and practice. After completing his medical degree, he pursued further specialized training in the UK, where he earned his MRCP from the Royal College of Physicians in Edinburgh in 1999, and later, an MSc in Diabetes and Endocrinology from the University of Liverpool in 2006. These early academic milestones laid the foundation for his later expertise in endocrinology and diabetes, fields that would define his career.

Professional Endeavors 🏥

Dr. Handrean Soran’s professional journey is marked by a dedication to medicine, particularly in the fields of endocrinology and diabetes. He has held significant roles in prestigious institutions, with his current position in the Department of Diabetes, Endocrinology, and Metabolism at Manchester University Hospitals NHS Foundation Trust. His medical career was further enhanced by his qualifications as a Fellow of the Royal College of Physicians (FRCP) from both Glasgow and Edinburgh. Throughout his career, Dr. Soran has worked on developing innovative approaches in clinical care and research, constantly striving to improve patient outcomes and advancing medical knowledge.

Contributions and Research Focus 🔬

Dr. Soran’s research focus primarily centers on diabetes, endocrinology, and cardiovascular health, specifically the interplay between metabolic disorders and heart disease. His research efforts have been integral to understanding the link between diabetes and cardiovascular risk, with a significant body of work examining the effects of treatments on these interconnected conditions. His contributions have been recognized through multiple high-impact publications in renowned journals such as the New England Journal of Medicine, Lancet, and European Heart Journal. With an H-index of 49 and over 130 citations, Dr. Soran’s work continues to shape the clinical landscape in these areas, driving further advancements in treatment protocols and therapeutic strategies for diabetes and cardiovascular diseases.

Accolades and Recognition 🏆

Dr. Soran’s career has been decorated with numerous accolades, affirming his status as a leader in his field. He achieved the prestigious title of Fellow of the Royal College of Physicians (FRCP) in both Edinburgh and Glasgow, a testament to his clinical expertise and contribution to medical science. His groundbreaking work in diabetes and cardiovascular research has earned him recognition not only from peers but also from major medical institutions. His publications in top-tier journals further highlight his academic prowess, solidifying his position as a key thought leader in the medical and academic communities.

Impact and Influence 🌍

Dr. Handrean Soran’s work extends beyond the realm of research publications; it has made a lasting impact on the clinical management of diabetes and cardiovascular diseases worldwide. His insights have contributed to shaping healthcare policies and clinical practices, particularly in the management of diabetic patients at high cardiovascular risk. Through his collaboration with the Division of Cardiovascular Sciences at the University of Manchester, he has fostered interdisciplinary approaches to solving complex medical challenges, advancing the integration of cardiovascular care with endocrinology. His work has influenced not only academic circles but also clinical practice, providing new directions for patient care.

Legacy and Future Contributions 🌱

As Dr. Soran continues his impactful work, his legacy is one of dedication to improving patient health outcomes and advancing the fields of endocrinology and diabetes. With a deep commitment to teaching and mentorship, Dr. Soran plays a pivotal role in training the next generation of doctors and researchers. His future contributions are poised to further explore the intricate relationship between metabolic disorders and cardiovascular health, addressing the growing global burden of these interconnected diseases. His work will undoubtedly continue to guide both clinical practice and future research in endocrinology, diabetes, and cardiovascular medicine, ensuring his ongoing influence in these critical areas.

Global Recognition and Influence 🌐

Dr. Soran’s influence reaches across borders, as evidenced by his extensive publication record and recognition within the global medical community. His research has not only enriched the scientific literature but also contributed to global health initiatives, particularly in the area of metabolic disorders and cardiovascular diseases. With collaborations spanning multiple continents, Dr. Soran is dedicated to improving health outcomes globally, offering expert insights into the prevention and management of diabetes and heart disease. His role in shaping clinical guidelines and his participation in international research collaborations further amplify his global impact.

Academic and Professional Leadership 🎓

In addition to his research contributions, Dr. Soran’s leadership within academia is profound. He holds multiple academic positions, including his affiliation with the University of Manchester, where he plays an integral role in advancing research within the Division of Cardiovascular Sciences. His leadership extends to mentoring young researchers and clinicians, helping to foster a new generation of experts in endocrinology and diabetes. Dr. Soran’s academic vision continues to drive progress in both education and research, making significant strides in improving how diabetes and cardiovascular diseases are understood and treated. His future work promises to leave a lasting mark on medical education and the advancement of scientific knowledge.

Publication

Cardiovascular efficacy and safety of bococizumab in high-risk patients
Author: PM Ridker
Year: 2017

Volanesorsen and triglyceride levels in familial chylomicronemia syndrome
Author: JL Witztum
Year: 2019

Triglyceride lowering with pemafibrate to reduce cardiovascular risk
Author: A Das Pradhan
Year: 2022

Diabetes dyslipidemia
Author: JD Schofield
Year: 2016

Lysosomal acid lipase deficiency–an under-recognized cause of dyslipidaemia and liver dysfunction
Author: Ž Reiner
Year: 2014

Obesity: a critical risk factor in the COVID‐19 pandemic
Author: S Kwok
Year: 2020

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
Author: KK Ray
Year: 2019

Hypercholesterolaemia and its management
Author: D Bhatnagar
Year: 2008

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
Author: B Williams
Year: 2018

Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset …
Author: FJ Raal
Year: 2017

Conclusion

Dr. Handrean Soran’s career is marked by profound contributions to medical science, particularly in the fields of diabetes and cardiovascular health. His groundbreaking research and clinical expertise have had a significant impact on both academic and healthcare practices worldwide. As a recognized leader in his field, Dr. Soran’s work continues to influence the management of metabolic and cardiovascular diseases, and his future contributions promise to further advance these critical areas of medical research and practice. His legacy is one of dedication, leadership, and a commitment to improving health outcomes globally.